<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
    May 2, 2011

    New TB Targets and Molecules Data Available for Public Access Use!

    Our collaboration with SRI is yielding some new public data sets that leverage the small molecules and TB data collected in CDD with the expertise in pathways databases. Dr. Malabika Sarker has completed curation of target gene links, pathways, protein structures, references and in vivo essentiality information for all leads and drugs for which we initially had TB target information. Now we have links to KEGG, TBDB, Pubmed, PDB etc.

    The “leads and targets” protocol can be combined with the “drugs and targets” protocol to result in over 700 molecules and can be found listed under TB drugs and leads with targets

    The set of 314 “in vivo essential targets” is perhaps the first public dataset in CDD which does not have small molecule content included. But it provides in one location for the first time gene, pathway and protein links for all of them. This database is TB target database for In vivo essential genes.

    These should be useful additions to our TB databases and could be useful finding similar structures that may mimic the molecules active against a particular target.


    Other posts you might be interested in

    View All Posts
    CDD Blog
    9 min   March 26, 2024
    Drug Discovery Industry Roundup with Barry Bunin — March 26, 2024
    Read More
    CDD Blog
    2 min   March 26, 2024
    Recorded Webinar: Trends & Better Practices for the Use of Gen AI & LLMs
    Read More
    CDD Blog
    2 min   March 22, 2024
    Recorded Webinar: Interdisciplinary Pathways in Medicine- from Neurodegenerative to Oncology Disease Research and Drug Discovery
    Read More